ADPT Adaptive Biotechnologies Corporation - Common Stock
NASDAQ · Life Sciences Tools & Services · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$28,35
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$12,0052-Wochen-Tief
$29,9652-Wochen-Hoch
Marktkapitalisierung (MRQ)
$4.51B
P/E (TTM)
-70.9
EPS (TTM)
$-0.40
Umsatz (TTM)
$308M
Ihre Abzeichen
52W-Spanne
$12–$30
Analystenbewertung
BUY
Kursziel
$27
P/E
-70.9
ROE
-39.6%
Nettogewinnmarge
-20.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ADPT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$28.35
Marktkapitalisierung (MRQ)
$4.51B
P/E (TTM)
-70.9
EPS (TTM)
$-0.40
Umsatz (TTM)
$308M
ROE (TTM)
-39.6%
Verschuldungsgrad (MRQ)
0.0
52W-Spanne
$12–$30
ADPT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Adaptive Biotechnologies Corporation - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheLife Sciences Tools & Services
Mitarbeiter624
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$277M2017-12-31 → 2025-12-31
EPS$-0.392020-12-31 → 2025-12-31
Freier Cashflow$-49M2019-12-31 → 2025-12-31
Nettogewinnmarge-20.7%2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ADPT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -70.95-Jahres-Durchschnitt ≈-14.9 | ≈-14.9 | · | · | |
| P/S (TTM) | 14.65-Jahres-Durchschnitt ≈9.9 | ≈9.9 | 4.6 | Überbewertet | |
| K/B (MRQ) | 31.65-Jahres-Durchschnitt ≈5.4 | ≈5.4 | 3.5 | Überbewertet | |
| EV / EBITDA | -77.45-Jahres-Durchschnitt ≈-18.1 | ≈-18.1 | · | · | |
| Kurs / FCF (TTM) | -187.65-Jahres-Durchschnitt ≈-17.1 | ≈-17.1 | · | · | |
| Kurs / Cashflow (TTM) | -214.65-Jahres-Durchschnitt ≈-18.9 | ≈-18.9 | · | · | |
| EV / Revenue (EV / Umsatz) | 16.05-Jahres-Durchschnitt ≈6.4 | ≈6.4 | · | · | |
| EV / FCF | -90.35-Jahres-Durchschnitt ≈-22.2 | ≈-22.2 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 31.75-Jahres-Durchschnitt ≈10.4 | ≈10.4 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ADPT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -12.2%5-Jahres-Durchschnitt ≈-97.6% | ≈-97.6% | 6.4% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -20.6%5-Jahres-Durchschnitt ≈-97.6% | ≈-97.6% | 7.0% | Schwach | |
| Pretax Margin (Vorgewinnmarge) | -21.5%5-Jahres-Durchschnitt ≈-97.1% | ≈-97.1% | 5.9% | Schwach | |
| Nettogewinnmarge (TTM) | -20.7%5-Jahres-Durchschnitt ≈-97.0% | ≈-97.0% | 2.4% | Schwach | |
| ROA (TTM) | -11.2%5-Jahres-Durchschnitt ≈-22.1% | ≈-22.1% | -0.64% | Schwach | |
| ROE (TTM) | -39.6%5-Jahres-Durchschnitt ≈-43.4% | ≈-43.4% | -0.84% | Schwach | |
| ROIC | -16.3% | · | -1.8% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ADPT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.05-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.7 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 4.85-Jahres-Durchschnitt ≈3.9 | ≈3.9 | 3.0 | Starke Liquidität | |
| Quick Ratio | 1.35-Jahres-Durchschnitt ≈1.2 | ≈1.2 | 2.2 | Starke Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.05-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.7 | Geringe Verschuldung | |
| Interest Coverage (Zinsdeckungsgrad) | -4.85-Jahres-Durchschnitt ≈-20.6 | ≈-20.6 | 3.7 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ADPT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 54.8%5-Jahres-Durchschnitt ≈25.7% | ≈25.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 14.3%5-Jahres-Durchschnitt ≈13.2% | ≈13.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 23.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ADPT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.55-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.5 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 7.85-Jahres-Durchschnitt ≈5.1 | ≈5.1 | 4.0 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 6.05-Jahres-Durchschnitt ≈6.5 | ≈6.5 | 6.2 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$443.9K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
51.3%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $-0.10 | $-0.14 | 26.7% |
| 31. März 2026 | $-0.12 | $-0.16 | 26.5% | |
| 31. Dezember 2025 | $-0.09 | $-0.18 | 51.3% | |
| 30. September 2025 | $0.06 | $-0.15 | 140.2% | |
| 30. Juni 2025 | $-0.17 | $-0.24 | 30.2% | |
| 31. März 2025 | $-0.20 | $-0.30 | 33.0% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $277M | $179M | $170M | $185M | $154M | $98M | $85M | $56M | |
| Cost of Revenue | $71M | $72M | $76M | $58M | $49M | $23M | $22M | $20M | |
| R&D Expense | $94M | $103M | $122M | $142M | $142M | $116M | $71M | $39M | |
| SG&A Expense | $73M | $73M | $84M | $89M | $75M | $50M | $30M | $20M | |
| Operating Expenses | $334M | $342M | $397M | $385M | $363M | $251M | $163M | $105M | |
| Operating Income | $-57M | $-163M | $-227M | $-200M | $-209M | $-153M | $-78M | $-50M | |
| Interest Expense | $12M | $12M | $14M | $4M | · | · | · | · | |
| Pretax Income | $-59M | $-160M | $-225M | $-200M | $-207M | $-146M | $-69M | · | |
| Income Tax | $0 | $0 | $0 | · | · | · | $0 | · | |
| Net Income | $-59M | $-159M | $-225M | $-200M | $-207M | $-146M | $-69M | $-46M | |
| EPS (Basic) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 | $-1.11 | · | · | |
| EPS (Diluted) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 | $-1.11 | · | · | |
| Shares (Basic) | 151,721,939 | 147,101,648 | 144,383,294 | 142,515,917 | 140,354,915 | 131,216,468 | · | · | |
| Shares (Diluted) | 151,721,939 | 147,101,648 | 144,383,294 | 142,515,917 | 140,354,915 | 131,216,468 | · | · | |
| EBITDA | $-57M | $-163M | $-227M | $-200M | $-209M | $-153M | $-78M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70M | $48M | $65M | $90M | $139M | $123M | $97M | $55M | |
| Receivables | $50M | $42M | $38M | $40M | $17M | $10M | $13M | $5M | |
| Inventory | $10M | $8M | $14M | $14M | $19M | $14M | $9M | $8M | |
| Prepaid Expense | $13M | $11M | $11M | $9M | $13M | $15M | $14M | $3M | |
| Current Assets | $300M | $284M | $410M | $562M | $403M | $727M | $613M | $181M | |
| PP&E (Net) | $34M | $49M | $68M | $83M | $85M | $40M | $60M | $19M | |
| PP&E (Gross) | $130M | $136M | $141M | $138M | $121M | $64M | $78M | $32M | |
| Accum. Depreciation | $96M | $88M | $73M | $54M | $36M | $24M | $18M | $12M | |
| Goodwill | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | |
| Intangibles | $2M | $3M | $5M | $7M | $9M | $10M | $12M | $14M | |
| Other Non-current Assets | $1M | $2M | $4M | $2M | $875.0K | $598.0K | $784.0K | $186.0K | |
| Total Assets | $513M | $539M | $661M | $857M | $923M | $1.12B | $912M | $333M | |
| Accounts Payable | $6M | $7M | $8M | $8M | $3M | $3M | $4M | $2M | |
| Accrued Liabilities | $8M | $8M | $9M | $12M | $9M | $13M | $4M | $3M | |
| Current Liabilities | $90M | $98M | $88M | $110M | $114M | $105M | $78M | $23M | |
| Capital Leases | $70M | $79M | $89M | $99M | $107M | $104M | · | · | |
| Other Non-current Liabilities | $20.0K | $20.0K | · | · | · | · | $93.0K | · | |
| Total Liabilities | $288M | $337M | $353M | $393M | $319M | $373M | $341M | $30M | |
| Long-term Debt | $131M | $133M | · | · | · | · | · | · | |
| Total Debt | $131M | $133M | $131M | · | · | · | · | · | |
| Common Stock | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $1.0K | |
| Paid-in Capital | $1.58B | $1.51B | $1.45B | $1.39B | $1.32B | $1.25B | $936M | $38M | |
| Retained Earnings | $-1.36B | $-1.30B | $-1.14B | $-919M | $-719M | $-512M | $-365M | $-296M | |
| AOCI | $253.0K | $166.0K | $215.0K | $-4M | $-1M | $893.0K | $671.0K | $-107.0K | |
| Stockholders' Equity | $219M | $203M | $308M | $464M | $604M | $743M | $571M | $-258M | |
| Liabilities + Equity | $513M | $539M | $661M | $857M | $923M | $1.12B | $912M | $333M | |
| Shares Outstanding | 153,779,418 | 147,773,744 | 145,082,271 | 143,105,002 | 141,393,865 | 137,646,896 | 125,238,142 | 12,841,536 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $16M | $17M | $20M | $21M | · | · | · | · | |
| Stock-based Comp | $51M | $54M | $63M | $55M | $43M | $25M | $13M | $11M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | · | $2M | · | $2M | · | · | · | · | |
| Operating Cash Flow | $-46M | $-95M | $-156M | $-184M | $-193M | $-150M | $205M | $-32M | |
| CapEx | $3M | $4M | $11M | $16M | $62M | $19M | $11M | $6M | |
| Investing Cash Flow | $38M | $78M | $130M | $3M | $181M | $-117M | $-482M | $736.0K | |
| Stock Issued | · | · | · | · | · | $272M | $321M | · | |
| Net Stock Activity | · | · | · | · | · | $272M | · | · | |
| Financing Cash Flow | $30M | $241.0K | $2M | $132M | $27M | $294M | $320M | $1M | |
| Net Change in Cash | $22M | $-17M | $-24M | $-49M | $16M | $27M | $44M | $-30M | |
| Free Cash Flow | $-49M | $-99M | $-167M | $-200M | $-254M | $-168M | $194M | · | |
| Levered FCF | $-61M | · | · | · | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% | -155.3% | -92.2% | · | |
| Net Margin | -21.5% | -89.1% | -132.3% | -108.0% | -134.3% | -148.6% | -80.7% | · | |
| Pretax Margin | -21.5% | -89.2% | -132.3% | -108.1% | -134.3% | · | · | · | |
| EBITDA Margin | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% | -155.3% | -92.2% | · | |
| ROA | -11.3% | -26.6% | -29.7% | -22.5% | -20.3% | -14.4% | -11.0% | · | |
| ROE | -28.2% | -62.4% | -58.3% | -37.5% | -30.8% | -23.0% | -11.9% | · | |
| ROIC | -16.3% | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.3 | 2.9 | 4.7 | 5.1 | 3.5 | 6.9 | 7.8 | · | |
| Quick Ratio | 1.3 | 0.9 | 1.2 | 1.2 | 1.4 | 1.3 | 1.4 | · | |
| Debt / Equity | 0.6 | 0.7 | 0.4 | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 0.4 | · | · | · | · | · | |
| Interest Coverage | -4.8 | -14.0 | -16.5 | -47.2 | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | · | |
| Inventory Turnover | 7.8 | 6.3 | 5.2 | 3.4 | 3.0 | 1.9 | 2.6 | · | |
| Receivables Turnover | 6.0 | 4.5 | 4.4 | 6.4 | 11.2 | 8.7 | 9.7 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.42 | $1.37 | $2.13 | $3.24 | $4.27 | $5.40 | $4.56 | · | |
| Revenue / Share | $1.83 | $1.22 | $1.18 | $1.30 | · | · | · | · | |
| Cash Flow / Share | $-0.30 | $-0.65 | $-1.08 | $-1.29 | · | · | · | · | |
| Cash / Share | $0.46 | $0.32 | $0.45 | $0.63 | $0.98 | $0.90 | $0.77 | · | |
| EPS (TTM) | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 | $-1.11 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 54.8% | 5.1% | -8.1% | 20.1% | 56.9% | · | · | · | |
| Revenue CAGR 3Y | 14.3% | 5.1% | 20.1% | · | · | · | · | · | |
| Revenue CAGR 5Y | 23.0% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $277M | $179M | $170M | $185M | $154M | $98M | $85M | · | |
| Net Income TTM | $-59M | $-159M | $-225M | $-200M | $-207M | $-146M | $-69M | · | |
| Market Cap | $2.50B | $886M | $711M | $1.09B | $3.97B | $8.14B | $3.75B | · | |
| Enterprise Value | $2.56B | $971M | $776M | · | · | · | · | · | |
| P/E | -41.6 | -5.6 | -3.1 | -5.5 | -19.0 | -53.3 | · | · | |
| P/S | 9.0 | 5.0 | 4.2 | 5.9 | 25.7 | 82.7 | 44.0 | · | |
| P/B | 11.4 | 4.4 | 2.3 | 2.4 | 6.6 | 11.0 | 6.6 | · | |
| P / Tangible Book | 25.5 | 11.0 | 3.9 | 3.2 | 8.3 | 13.3 | · | · | |
| P / Cash Flow | -54.3 | -9.3 | -4.5 | -5.9 | -20.6 | -54.4 | 18.2 | · | |
| P / FCF | -51.0 | -9.0 | -4.3 | -5.5 | -15.6 | -48.3 | 19.3 | · | |
| EV / EBITDA | -44.8 | -6.0 | -3.4 | · | · | · | · | · | |
| EV / FCF | -52.3 | -9.8 | -4.6 | · | · | · | · | · | |
| EV / Revenue | 9.2 | 5.4 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -2.4% | -18.0% | -31.8% | -18.3% | -5.3% | -1.9% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $71M | $72M | $94M | $59M | $52M | $47M | $46M | $43M | $42M | $46M | $38M | $49M | $38M | $48M | $44M | |
| Cost of Revenue | $20M | $19M | $18M | $18M | $18M | $17M | $18M | $17M | $19M | $18M | $20M | $19M | $18M | $19M | $15M | $13M | |
| R&D Expense | $19M | $24M | $22M | $24M | $24M | $24M | $23M | $24M | $25M | $30M | $29M | $29M | $32M | $33M | $36M | $37M | |
| SG&A Expense | $21M | $21M | $20M | $18M | $18M | $17M | $18M | $17M | $18M | $20M | $21M | $20M | $22M | $21M | $21M | $21M | |
| Operating Expenses | $87M | $90M | $84M | $84M | $84M | $82M | $81M | $79M | $91M | $91M | $117M | $89M | $97M | $95M | $93M | $96M | |
| Operating Income | $-16M | $-19M | $-13M | $10M | $-25M | $-30M | $-34M | $-33M | $-47M | $-49M | $-71M | $-51M | $-48M | $-57M | $-45M | $-53M | |
| Interest Expense | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $653.0K | · | |
| Net Income | $-40M | $-20M | $-14M | $10M | $-26M | $-30M | $-34M | $-32M | $-46M | $-48M | $-69M | $-50M | $-48M | $-58M | $-45M | $-52M | |
| EPS (Basic) | $-0.25 | $-0.13 | $-0.08 | $0.06 | $-0.17 | $-0.20 | $-0.22 | $-0.22 | $-0.31 | $-0.33 | $-0.48 | $-0.35 | $-0.33 | $-0.40 | $-0.32 | $-0.37 | |
| EPS (Diluted) | $-0.25 | $-0.13 | $-0.08 | $0.06 | $-0.17 | $-0.20 | $-0.22 | $-0.22 | $-0.31 | $-0.33 | $-0.48 | $-0.35 | $-0.33 | $-0.40 | $-0.32 | $-0.37 | |
| Shares (Basic) | 159,855,257 | 155,521,048 | · | 152,432,307 | 152,082,284 | 149,195,028 | · | 147,516,398 | 147,414,095 | 145,787,527 | · | 144,704,868 | 144,397,693 | 143,511,142 | 142,928,654 | 142,363,589 | |
| Shares (Diluted) | 159,855,257 | 155,521,048 | · | 163,162,107 | 152,082,284 | 149,195,028 | · | 147,516,398 | 147,414,095 | 145,787,527 | · | 144,704,868 | 144,397,693 | 143,511,142 | 142,928,654 | 142,363,589 | |
| EBITDA | $-16M | $-19M | · | $10M | $-25M | $-30M | · | $-33M | $-47M | $-49M | · | $-51M | $-48M | $-57M | $-45M | $-53M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $170M | $78M | $70M | $55M | $43M | $51M | $48M | $38M | $60M | $71M | · | $89M | $109M | $95M | $218M | $76M | |
| Receivables | $50M | $48M | $50M | $45M | $44M | $44M | $42M | $41M | $36M | $42M | · | $31M | $32M | $31M | $27M | $24M | |
| Inventory | $10M | $11M | $10M | $10M | $8M | $9M | $8M | $12M | $13M | $13M | · | $19M | $19M | $20M | $17M | $19M | |
| Prepaid Expense | $16M | $14M | $13M | $14M | $11M | $11M | $11M | $12M | $11M | $10M | · | $13M | $9M | $10M | $12M | $12M | |
| Current Assets | $421M | $292M | $300M | $281M | $262M | $256M | $284M | $308M | $352M | $374M | · | $435M | $477M | $501M | $564M | $439M | |
| PP&E (Net) | $29M | $31M | $34M | $37M | $41M | $44M | $49M | $51M | $55M | $65M | · | $77M | $79M | $81M | $87M | $87M | |
| PP&E (Gross) | · | · | $130M | · | · | · | $136M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $96M | · | · | · | $88M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | $119M | · | $119M | $119M | $119M | $119M | $119M | |
| Intangibles | $884.0K | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | · | $6M | $6M | $6M | $7M | $8M | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | · | $3M | $3M | $2M | $2M | $778.0K | |
| Total Assets | $641M | $506M | $513M | $491M | $497M | $511M | $539M | $559M | $585M | $620M | · | $718M | $765M | $791M | $884M | $807M | |
| Accounts Payable | $5M | $10M | $6M | $10M | $7M | $6M | $7M | $7M | $10M | $12M | · | $4M | $9M | $6M | $4M | $3M | |
| Accrued Liabilities | $11M | $7M | $8M | $7M | $7M | $8M | $8M | $6M | $7M | $8M | · | $10M | $8M | $8M | $11M | $9M | |
| Current Liabilities | $88M | $87M | $90M | $83M | $92M | $88M | $98M | $88M | $88M | $83M | · | $93M | $95M | $90M | $104M | $111M | |
| Capital Leases | $67M | $69M | $70M | $72M | $74M | $76M | $79M | $82M | $84M | $87M | · | $92M | $94M | $96M | $101M | $103M | |
| Other Non-current Liabilities | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $490M | $282M | $288M | $286M | $317M | $321M | $337M | $335M | $343M | $346M | · | $356M | $369M | $368M | $396M | $288M | |
| Long-term Debt | $0 | $131M | $131M | $132M | $134M | $134M | $133M | · | · | · | · | $130M | · | · | · | · | |
| Total Debt | $0 | $131M | · | $132M | $134M | $134M | · | $133M | $132M | $132M | · | $130M | · | · | · | · | |
| Common Stock | $16.0K | $16.0K | $15.0K | $15.0K | $15.0K | $15.0K | $14.0K | $14.0K | $14.0K | $14.0K | · | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | |
| Paid-in Capital | $1.57B | $1.60B | $1.58B | $1.55B | $1.54B | $1.52B | $1.51B | $1.49B | $1.48B | $1.47B | · | $1.44B | $1.42B | $1.40B | $1.37B | $1.36B | |
| Retained Earnings | $-1.42B | $-1.38B | $-1.36B | $-1.35B | $-1.36B | $-1.33B | $-1.30B | $-1.27B | $-1.24B | $-1.19B | · | $-1.07B | $-1.02B | $-977M | $-879M | $-834M | |
| AOCI | $-212.0K | $-28.0K | $253.0K | $211.0K | $73.0K | $134.0K | $166.0K | $497.0K | $-182.0K | $-106.0K | · | $-250.0K | $-893.0K | $-2M | $-6M | $-6M | |
| Stockholders' Equity | $143M | $216M | $219M | $204M | $180M | $190M | $203M | $224M | $242M | $275M | · | $362M | $396M | $424M | $488M | $518M | |
| Liabilities + Equity | $641M | $506M | $513M | $491M | $497M | $511M | $539M | $559M | $585M | $620M | · | $718M | $765M | $791M | $884M | $807M | |
| Shares Outstanding | 159,059,622 | 159,697,221 | 153,779,418 | 152,581,042 | 152,234,772 | 151,916,722 | 147,773,744 | 147,561,586 | 147,462,201 | 147,368,324 | · | 144,772,751 | 144,645,118 | 144,279,969 | 142,987,127 | 142,784,868 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $3M | $6M | $6M | $5M | · | · | |
| Stock-based Comp | $11M | $12M | $13M | $13M | $13M | $12M | $13M | $14M | $13M | $14M | $16M | $15M | $17M | $15M | $14M | $14M | |
| Amort. of Intangibles | $423.0K | $419.0K | $429.0K | $428.0K | $423.0K | $419.0K | $428.0K | $428.0K | $424.0K | $423.0K | $429.0K | $428.0K | $423.0K | $419.0K | $428.0K | $423.0K | |
| Restructuring | · | $643.0K | · | · | · | $0 | $87.0K | $193.0K | $680.0K | $1M | · | · | · | · | · | · | |
| Operating Cash Flow | $-6M | $-10M | $2M | $-7M | $-12M | $-28M | $-12M | $-27M | $-17M | $-38M | $-27M | $-47M | $-24M | $-59M | $-42M | $-47M | |
| CapEx | $1M | $796.0K | $636.0K | $409.0K | $655.0K | $1M | $80.0K | $344.0K | $2M | $2M | $1M | $3M | $4M | $3M | $5M | $5M | |
| Investing Cash Flow | $-43M | $9M | $-8M | $17M | $3M | $26M | $22M | $5M | $6M | $45M | $3M | $26M | $37M | $63M | $58M | $5M | |
| Financing Cash Flow | $142M | $8M | $22M | $2M | $2M | $5M | $127.0K | $40.0K | $30.0K | $44.0K | $87.0K | $17.0K | $1M | $672.0K | $126M | $4M | |
| Net Change in Cash | $92M | $7M | $15M | $12M | $-7M | $3M | $10M | $-22M | $-11M | $6M | $-24M | $-21M | $15M | $4M | $141M | $-38M | |
| Free Cash Flow | · | $-10M | · | · | · | $-30M | · | · | · | $-40M | · | · | · | $-62M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -22.0% | -27.1% | · | 10.9% | -42.5% | -56.5% | · | -70.3% | -109.6% | -116.5% | · | -134.4% | -97.7% | -151.9% | -95.0% | -120.2% | |
| Net Margin | -55.6% | -28.3% | · | 10.2% | -43.5% | -56.9% | · | -69.1% | -107.0% | -113.5% | · | -132.7% | -97.7% | -153.3% | -94.7% | -119.2% | |
| EBITDA Margin | -22.0% | -27.1% | · | 10.9% | -42.5% | -56.5% | · | -70.3% | -109.6% | -116.5% | · | -134.4% | -97.7% | -151.9% | -95.0% | -120.2% | |
| ROA | -7.0% | -3.9% | · | 1.8% | -4.7% | -5.3% | · | -5.0% | -6.9% | -6.7% | · | -6.3% | -6.1% | -7.0% | -4.8% | -5.7% | |
| ROE | -24.7% | -9.8% | · | 4.5% | -12.2% | -12.8% | · | -10.9% | -14.5% | -13.6% | · | -11.8% | -10.5% | -11.8% | -8.0% | -8.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | 3.4 | · | 3.4 | 2.8 | 2.9 | · | 3.5 | 4.0 | 4.5 | · | 4.7 | 5.0 | 5.6 | 5.4 | 3.9 | |
| Quick Ratio | 2.5 | 1.4 | · | 1.2 | 0.9 | 1.1 | · | 0.9 | 1.1 | 1.4 | · | 1.3 | 1.5 | 1.4 | 2.3 | 0.9 | |
| Debt / Equity | 0.0 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | · | · | · | · | |
| LT Debt / Equity | 0.0 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | · | · | · | · | |
| Interest Coverage | -5.9 | -6.6 | · | 3.5 | -8.5 | -10.2 | · | -11.1 | -17.6 | -16.3 | · | -14.0 | -13.3 | -16.2 | -69.6 | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | |
| Inventory Turnover | 2.1 | 1.9 | · | 1.7 | 1.7 | 1.5 | · | 1.1 | 1.2 | 1.1 | · | 1.1 | 0.9 | 0.9 | 0.8 | 0.7 | |
| Receivables Turnover | 1.5 | 1.5 | · | 2.2 | 1.5 | 1.2 | · | 1.3 | 1.3 | 1.1 | · | 1.3 | 1.8 | 1.4 | 2.2 | 2.3 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.90 | $1.35 | · | $1.34 | $1.18 | $1.25 | · | $1.52 | $1.64 | $1.87 | · | $2.50 | $2.74 | $2.94 | $3.41 | $3.63 | |
| Revenue / Share | $0.45 | $0.46 | · | $0.58 | $0.39 | $0.35 | · | $0.31 | $0.29 | $0.29 | · | $0.26 | $0.34 | $0.26 | $0.33 | $0.31 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.19 | · | · | · | $-0.26 | · | · | · | $-0.41 | · | · | |
| Cash / Share | $1.07 | $0.49 | · | $0.36 | $0.28 | $0.33 | · | $0.26 | $0.41 | $0.48 | · | $0.61 | $0.76 | $0.66 | $1.52 | $0.54 | |
| EPS (TTM) | $-0.40 | $-0.32 | · | $-0.53 | $-0.81 | $-0.95 | · | $-1.34 | $-1.47 | $-1.49 | · | $-1.35 | $-1.32 | $-1.36 | $-1.57 | $-1.65 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $308M | $295M | · | $253M | $205M | $190M | · | $177M | $169M | $175M | · | $180M | $190M | $184M | $168M | $160M | |
| Net Income TTM | $-64M | $-50M | · | $-80M | $-121M | $-142M | · | $-195M | $-213M | $-215M | · | $-196M | $-191M | $-195M | $-221M | $-232M | |
| Market Cap | $3.41B | $2.22B | · | $2.28B | $1.77B | $1.13B | · | $756M | $534M | $473M | · | $789M | $971M | $1.27B | $1.02B | $1.16B | |
| Enterprise Value | $3.24B | $2.27B | · | $2.36B | $1.86B | $1.21B | · | $850M | $606M | $533M | · | $830M | · | · | · | · | |
| P/E | -53.6 | -43.4 | · | -28.2 | -14.4 | -7.8 | · | -3.8 | -2.5 | -2.2 | · | -4.0 | -5.1 | -6.5 | -4.5 | -4.9 | |
| P/S | 11.1 | 7.5 | · | 9.0 | 8.6 | 6.0 | · | 4.3 | 3.2 | 2.7 | · | 4.4 | 5.1 | 6.9 | 6.1 | 7.2 | |
| P/B | 23.9 | 10.2 | · | 11.2 | 9.9 | 5.9 | · | 3.4 | 2.2 | 1.7 | · | 2.2 | 2.5 | 3.0 | 2.1 | 2.2 | |
| P / Tangible Book | 148.0 | 23.1 | · | 27.4 | 30.5 | 16.5 | · | 7.5 | 4.5 | 3.1 | · | 3.3 | 3.6 | 4.3 | 2.8 | 2.9 | |
| P / Cash Flow | · | -232.4 | · | · | · | -39.6 | · | · | · | -12.3 | · | · | · | -21.5 | · | · | |
| EV / Revenue | 10.5 | 7.7 | · | 9.3 | 9.1 | 6.4 | · | 4.8 | 3.6 | 3.1 | · | 4.6 | · | · | · | · | |
| Earnings Yield | -1.9% | -2.3% | · | -3.5% | -7.0% | -12.8% | · | -26.2% | -40.6% | -46.4% | · | -24.8% | -19.7% | -15.4% | -22.1% | -20.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $277M | $179M | $170M | $185M | $154M |
| Betriebsgewinnmarge % | -20.6% | -90.8% | -133.3% | -108.0% | -135.4% |
| Nettoergebnis | $-59M | $-159M | $-225M | $-200M | $-207M |
| Verwässerte EPS | $-0.39 | $-1.08 | $-1.56 | $-1.40 | $-1.48 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.6 | 0.7 | 0.4 | · | · |
| Liquiditätsgrad | 3.3 | 2.9 | 4.7 | 5.1 | 3.5 |
| Quick Ratio | 1.3 | 0.9 | 1.2 | 1.2 | 1.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-49M | $-99M | $-167M | $-200M | $-254M |
Institutionelle Eigentümer (13F) 312 Einreicher · $3.5B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
312
Gehaltener Wert
$3.5B
Neue Positionen
46
Geschlossene Positionen
37
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 46 (-11 vs. Vorquartal) | 37 (0 vs. Vorquartal) | 113 (+14 vs. Vorquartal) | 85 (-12 vs. Vorquartal) | +17.2M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | $643.365.037 | 29.993.708 | 18,50% | Aktien |
| BlackRock, Inc. | $324.734.962 | 15.139.159 | 9,34% | Aktien |
| VANGUARD GROUP INC | $183.222.148 | 11.282.152 | 5,27% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $137.356.941 | 6.403.587 | 3,95% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $126.798.802 | 5.911.366 | 3,65% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.465.155 | 5.476.231 | 3,38% | Aktien |
| D. E. Shaw & Co., Inc. | $99.224.675 | 4.625.859 | 2,85% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $91.540.985 | 4.267.645 | 2,63% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $78.131.203 | 3.641.837 | 2,25% | Aktien |
| STATE STREET CORP | $74.181.636 | 3.458.388 | 2,13% | Aktien |
| Invesco Ltd. | $66.366.535 | 3.094.011 | 1,91% | Aktien |
| GOLDMAN SACHS GROUP INC | $64.011.670 | 2.984.227 | 1,84% | Aktien |
| UBS Group AG | $61.392.474 | 2.862.120 | 1,77% | Kaufoption |
| Driehaus Capital Management LLC | $54.219.229 | 2.527.703 | 1,56% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $54.153.099 | 2.524.620 | 1,56% | Aktien |
| Nuveen, LLC | $50.754.025 | 2.366.155 | 1,46% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $46.810.892 | 2.182.326 | 1,35% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $44.879.492 | 2.092.284 | 1,29% | Aktien |
| ARK Investment Management LLC | $44.837.058 | 2.090.306 | 1,29% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $42.284.385 | 1.971.300 | 1,22% | Kaufoption |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $40.523.000 | 1.889.188 | 1,17% | Aktien |
| Aristotle Atlantic Partners, LLC | $39.436.104 | 1.838.513 | 1,13% | Aktien |
| TORONTO DOMINION BANK | $38.610.000 | 1.800.000 | 1,11% | Kaufoption |
| BANK OF AMERICA CORP /DE/ | $37.109.444 | 1.730.044 | 1,07% | Aktien |
| JANE STREET GROUP, LLC | $34.116.504 | 1.590.513 | 0,98% | Aktien |
| NORTHERN TRUST CORP | $32.332.679 | 1.507.351 | 0,93% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $28.525.411 | 1.329.856 | 0,82% | Aktien |
| Amova Asset Management Americas, Inc. | $28.512.113 | 1.329.856 | 0,82% | Aktien |
| OBERWEIS ASSET MANAGEMENT INC/ | $27.000.209 | 1.258.751 | 0,78% | Aktien |
| PERCEPTIVE ADVISORS LLC | $26.111.621 | 1.217.325 | 0,75% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.279.940 | 1.178.552 | 0,73% | Aktien |
| AMERIPRISE FINANCIAL INC | $23.332.376 | 1.087.754 | 0,67% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $22.993.006 | 1.071.935 | 0,66% | Aktien |
| Blue Water Life Science Advisors, LP | $21.667.610 | 1.010.145 | 0,62% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $20.049.508 | 934.709 | 0,58% | Aktien |
| Aberdeen Group plc | $19.712.507 | 918.998 | 0,57% | Aktien |
| Freestone Grove Partners LP | $18.912.208 | 881.688 | 0,54% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $18.228.103 | 849.795 | 0,52% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $16.857.619 | 785.903 | 0,48% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $16.679.842 | 777.615 | 0,48% | Aktien |
| MORGAN STANLEY | $16.435.667 | 766.230 | 0,47% | Aktien |
| Granite Investment Partners, LLC | $16.242.305 | 757.217 | 0,47% | Aktien |
| Trexquant Investment LP | $15.792.777 | 736.260 | 0,45% | Aktien |
| FMR LLC | $15.219.503 | 709.534 | 0,44% | Aktien |
| JENNISON ASSOCIATES LLC | $14.718.882 | 686.195 | 0,42% | Aktien |
| Hillsdale Investment Management Inc. | $14.676.454 | 684.217 | 0,42% | Aktien |
| NEXT CENTURY GROWTH INVESTORS LLC | $13.080.853 | 609.830 | 0,38% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $11.657.753 | 543.485 | 0,34% | Aktien |
| ExodusPoint Capital Management, LP | $11.114.232 | 518.146 | 0,32% | Aktien |
| SEI INVESTMENTS CO | $10.935.157 | 509.797 | 0,31% | Aktien |
Unternehmensinsider 27 Insider · 17 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Chad M Robins | CEO and Chairman | 18. August 2026 M | 2.180.518 | 0 | 19 | $-39.801.326 |
| Kyle Piskel | Chief Financial Officer | 18. Mai 2026 S | 256.725 | 0 | 6 | $-3.581.681 |
| Tycho Peterson | Chief Financial Officer | 5. März 2024 S | 531.553 | 0 | 0 | $0 |
| Chad M Cohen | Chief Financial Officer | 22. Dezember 2021 M | 21.604 | 0 | 0 | $0 |
| Julie Rubinstein | President and COO | 27. April 2026 M | 377.802 | 0 | 47 | $-13.371.115 |
| Mark R Adams | Chief Operating Officer | 11. April 2023 S | 175.361 | 0 | 0 | $0 |
| Francis Lo | Chief People Officer | 16. September 2026 M | 220.867 | 0 | 15 | $-13.213.683 |
| Susan Bobulsky | Chief Commercial Officer, MRD | 15. September 2026 S | 395.794 | 0 | 9 | $-1.204.076 |
| Harlan S Robins | Chief Scientific Officer | 21. Juli 2026 M | 812.058 | 0 | 17 | $-29.647.952 |
| Sharon Benzeno | Chief Commercial Ofc Imm Med | 29. Juni 2026 M | 221.278 | 0 | 6 | $-14.690.980 |
| Stacy L Taylor | SVP and General Counsel | 22. August 2024 S | 139.365 | 0 | 0 | $0 |
| Nitin Sood | Chief Commercial Officer, MRD | 8. August 2023 S | 214.808 | 0 | 0 | $0 |
| Lance Baldo | Chief Medical Officer | 8. März 2022 S | 17.171 | 0 | 0 | $0 |
| Jyoti Palaniappan | SVP, Diagnostics, T-Detect | 19. Juli 2021 M | 9.158 | 0 | 0 | $0 |
| Henning Thorsen | SVP, Commercial Operations | 17. Mai 2021 A | 29.061 | 0 | 0 | $0 |
| Nancy Louise Hill | EVP, Operations & Program Mana | 19. Januar 2021 M | 10.000 | 0 | 0 | $0 |
| Charles Sang | SVP, External Affairs | 11. Dezember 2020 M | 0 | 0 | 0 | $0 |
| Katey Einterz Owen | Direktor | 31. August 2026 G | 66.100 | 0 | 1 | $-249.990 |
| Robert Hershberg | Direktor | 18. August 2026 M | 46.683 | 0 | 3 | $-1.115.696 |
| Peter M Neupert | Direktor | 17. August 2026 M | 130.625 | 0 | 3 | $-3.135.850 |
| Michelle Renee Griffin | Direktor | 25. Juni 2026 M | 15.625 | 0 | 3 | $-2.000.259 |
| Michael J Pellini | Direktor | 4. März 2025 A | 69.690 | 0 | 0 | $0 |
| Kevin T Conroy | Direktor | 6. März 2023 A | 22.968 | 0 | 0 | $0 |
| Leslie Trigg | Direktor | 6. März 2023 A | 25.907 | 0 | 0 | $0 |
| David E. Goel | Direktor | 15. Februar 2021 A | 1.504 | 0 | 0 | $0 |
| Andris A Zoltners | Direktor | 13. Februar 2020 A | 3.621.016 | 0 | 0 | $0 |
| Eric Dobmeier | · | 14. Februar 2021 A | 1.504 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 35 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 2,57% | 1.774.756 NS | 31. Juli 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,11% | 64.619 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,26% | 186.189 SH | 2. Oktober 2026 | Täglich |
| MEDI · Harbor ETF Trust | 0,98% | 17.855 NS | 31. Juli 2026 | N-PORT |
| BRNY · EA Series Trust | 0,57% | 147.197 NS | 31. Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,57% | 327.285 NS | 31. Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,29% | 11.293 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,28% | 1.179.205 SH | 11. September 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,27% | 162.673 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,24% | 1.444.121 SH | 11. September 2026 | Täglich |
| ESSC · Strategy Shares | 0,24% | 3.763 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,19% | 165.252 SH | 19. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 42.053 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,12% | 49.206 SH | 11. September 2026 | Täglich |
| IWM · iShares Trust | 0,12% | 3.941.006 SH | 11. September 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,12% | 29.650 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,11% | 73.784 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 886.884 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,09% | 85.150 SH | 2. Oktober 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 69.841 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,06% | 51.690 SH | 19. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,04% | 1.011.327 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 345.932 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 55.701 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.415.247 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,03% | 7.584 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,02% | 1.746.783 SH | 19. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.197 SH | 2. Oktober 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 9.559 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 43.739 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 170.690 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.835.465 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12.307 SH | 19. August 2026 | Täglich |
| ISCB · iShares Trust | · | 6.963 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 172.353 SH | 11. September 2026 | Täglich |
ADPT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$27.25
-3,9%
5 35,7%
Starker Kauf
7 50,0%
Kauf
2 14,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-09-30Mittelwert-Ziel $27.44 -3,2%
Jetzt
Aktueller Preis $28.35
Tief$21.00
Mittelwert$27.44
Hoch$35.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ADPT | $2.50B | -41.6 | 54.8% | -21.5% | -28.2% | · |
| AVTR | $7.82B | -14.7 | -3.4% | -8.1% | -8.9% | 32.6% |
| RGEN | $9.23B | 190.5 | 16.4% | 6.6% | 2.4% | · |
| BRKR | $7.17B | -314.1 | 2.1% | -0.25% | -0.40% | 45.9% |
| BIO | · | · | · | · | · | · |
| SHC | $5.02B | 65.3 | 5.7% | 6.7% | 14.0% | 55.5% |
| ALMR | · | · | · | · | · | · |
| MRVI | · | -3.6 | -28.3% | -70.4% | -48.6% | 18.3% |
| FTRE | $1.61B | -1.6 | 1.0% | -36.2% | -171.1% | · |
| BLFS | · | -241.8 | 28.9% | · | · | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Adaptive Biotech (ADPT) Reports 35% Revenue Growth Driven by Strong clonoSEQ Performance in Q1 2026
Yahoo Finance · 3 Monate, 4 Wochen vor
Adaptive Biotechnologies' Chief Operating Officer verkaufte über 19.000 Unternehmensaktien. Hier ist, was das für Investoren bedeutet.
Nasdaq · 4 Monate, 4 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026